R. Clay Bunn

3.2k total citations
46 papers, 2.6k citations indexed

About

R. Clay Bunn is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, R. Clay Bunn has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Oncology. Recurrent topics in R. Clay Bunn's work include Bone health and treatments (10 papers), Bone Metabolism and Diseases (10 papers) and Metabolism, Diabetes, and Cancer (9 papers). R. Clay Bunn is often cited by papers focused on Bone health and treatments (10 papers), Bone Metabolism and Diseases (10 papers) and Metabolism, Diabetes, and Cancer (9 papers). R. Clay Bunn collaborates with scholars based in United States, Denmark and Australia. R. Clay Bunn's co-authors include John L. Fowlkes, Kathryn M. Thrailkill, Charles K. Lumpkin, Gael Cockrell, Stephen F. Kemp, Brent C. Reed, Elizabeth C. Wahl, Jeffry S. Nyman, Lichu Liu and Evangelia Kalaitzoglou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Molecular and Cellular Biology.

In The Last Decade

R. Clay Bunn

46 papers receiving 2.5k citations

Peers

Countries citing papers authored by R. Clay Bunn

Since Specialization

Citations

This map shows the geographic impact of R. Clay Bunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Clay Bunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Clay Bunn more than expected).

Fields of papers citing papers by R. Clay Bunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Clay Bunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Clay Bunn. The network helps show where R. Clay Bunn may publish in the future.

Co-authorship network of co-authors of R. Clay Bunn

This figure shows the co-authorship network connecting the top 25 collaborators of R. Clay Bunn. A scholar is included among the top collaborators of R. Clay Bunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Clay Bunn. R. Clay Bunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes 2022 ·Acta Histochemica ·Sarah D. McDonald, (unknown), R. Clay Bunn, John L. Fowlkes, Kathryn M. Thrailkill, Iuliana Popescu	1
2	Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits 2020 ·Bone ·Kathryn M. Thrailkill, R. Clay Bunn, Sasidhar Uppuganti, (unknown), Iuliana Popescu, Evangelia Kalaitzoglou, John L. Fowlkes, Jeffry S. Nyman	14
3	Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization 2019 ·Bone ·John L. Fowlkes, R. Clay Bunn, (unknown), Evangelia Kalaitzoglou, Sasidhar Uppuganti, Mustafa Ünal, Jeffry S. Nyman, Kathryn M. Thrailkill	8
4	Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes 2017 ·Bone Reports ·Jeffry S. Nyman, Evangelia Kalaitzoglou, R. Clay Bunn, Sasidhar Uppuganti, Kathryn M. Thrailkill, John L. Fowlkes	28
5	Nutlin‐3 treatment spares cisplatin‐induced inhibition of bone healing while maintaining osteosarcoma toxicity 2016 ·Journal of Orthopaedic Research® ·Kimo C. Stine, Elizabeth C. Wahl, Lichu Liu, Robert A. Skinner, (unknown), R. Clay Bunn, Corey Montgomery, James Aronson, David L. Becton, Richard W. Nicholas, Christopher J. Swearingen, Larry J. Suva, Charles K. Lumpkin	6
6	The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes 2016 ·Bone ·Kathryn M. Thrailkill, Jeffry S. Nyman, R. Clay Bunn, Sasidhar Uppuganti, Katherine Thompson, Charles K. Lumpkin, Evangelia Kalaitzoglou, John L. Fowlkes	56
7	Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts 2016 ·Current Osteoporosis Reports ·Evangelia Kalaitzoglou, Iuliana Popescu, R. Clay Bunn, John L. Fowlkes, Kathryn M. Thrailkill	87
8	SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice 2015 ·Bone ·Kathryn M. Thrailkill, R. Clay Bunn, Jeffry S. Nyman, Mallikarjuna Rettiganti, Gael Cockrell, Elizabeth C. Wahl, Sasidhar Uppuganti, Charles K. Lumpkin, John L. Fowlkes	63
9	Increasing duration of type 1 diabetes perturbs the strength–structure relationship and increases brittleness of bone 2010 ·Bone ·Jeffry S. Nyman, Jesse L. Even, Chan‐Hee Jo, Erik G. Herbert, (unknown), Gael Cockrell, Elizabeth C. Wahl, R. Clay Bunn, Charles K. Lumpkin, John L. Fowlkes, Kathryn M. Thrailkill	89
10	Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus 2010 ·Endocrine ·Kathryn M. Thrailkill, Cynthia Moreau, Gael Cockrell, Chan‐Hee Jo, R. Clay Bunn, (unknown), Charles K. Lumpkin, John L. Fowlkes	57
11	Direct bone formation during distraction osteogenesis does not require TNFα receptors and elevated serum TNFα fails to inhibit bone formation in TNFR1 deficient mice 2009 ·Bone ·Elizabeth C. Wahl, James Aronson, Lichu Liu, Robert A. Skinner, (unknown), Gael Cockrell, John L. Fowlkes, Kathryn M. Thrailkill, R. Clay Bunn, Martin J. J. Ronis, Charles K. Lumpkin	15
12	Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy 2008 ·Endocrine ·Kathryn M. Thrailkill, R. Clay Bunn, John L. Fowlkes	154
13	Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type) 2007 ·Growth Hormone & IGF Research ·John L. Fowlkes, R. Clay Bunn, Hannah Coleman, Bryan D. Hall, (unknown), Kathryn M. Thrailkill	7
14	A novel rat model for the study of deficits in bone formation in type-2 diabetes 2007 ·Acta Orthopaedica ·Zhendong Liu, James Aronson, Elizabeth C. Wahl, Lichu Liu, Daniel S. Perrien, (unknown), John L. Fowlkes, Kathryn M. Thrailkill, R. Clay Bunn, Gael Cockrell, Robert A. Skinner, Charles K. Lumpkin	40
15	GLUT1CBP(TIP2/GIPC1) Interactions with GLUT1 and Myosin VI: Evidence Supporting an Adapter Function for GLUT1CBP 2005 ·Molecular Biology of the Cell ·Brent C. Reed, (unknown), Bryan H. Bellaire, James A. Cardelli, Thomas Louis, (unknown), (unknown), R. Clay Bunn	54
16	IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts 2004 ·Biochemical and Biophysical Research Communications ·R. Clay Bunn, (unknown), Michael T. Overgaard, Claus Oxvig, John L. Fowlkes	9
17	Regulation of Insulin-Like Growth Factor (IGF)-I Action by Matrix Metalloproteinase-3 Involves Selective Disruption of IGF-I/IGF-Binding Protein-3 Complexes 2003 ·Endocrinology ·John L. Fowlkes, Delila Serra, R. Clay Bunn, Kathryn M. Thrailkill, Jan J. Enghild, Hideaki Nagase	56
18	Insulin-like growth factor binding protein proteolysis 2003 ·Trends in Endocrinology and Metabolism ·R. Clay Bunn, John L. Fowlkes	197
19	Synaptic glutamate receptor clustering in mice lacking the SH3 and GK domains of SAP97 2002 ·European Journal of Neuroscience ·Nikolaj Klöcker, R. Clay Bunn, Eric Schnell, Georgina Caruana, Alan Bernstein, Roger A. Nicoll, David S. Bredt	26
20	Postsynaptic Targeting of Alternative Postsynaptic Density-95 Isoforms by Distinct Mechanisms 2002 ·Journal of Neuroscience ·Dane M. Chetkovich, R. Clay Bunn, Sheng‐Han Kuo, Yoshimi Kawasaki, Minoree Kohwi, David S. Bredt	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact